Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Febuxostat> ?p ?o. }
Showing items 1 to 95 of
95
with 100 items per page.
- Febuxostat abstract "Febuxostat (INN; trade names: Adenuric in Europe and New Zealand, Febutaz in India and Takeda's Uloric in the US) is a urate lowering drug, an inhibitor of xanthine oxidase that is indicated for use in the treatment of hyperuricemia and chronic gout.Febuxostat received marketing approval by the European Medicines Agency on April 21, 2008 and was approved by the U.S. Food and Drug Administration on February 16, 2009.A study comparing febuxostat to allopurinol found that more individuals treated with febuxostat had decreased levels of uric acid, but there was no difference in the amount of initial gout flares or the surface area of gout tophi.A committee of the British National Institute for Health and Clinical Excellence concluded that although febuxostat had been shown to be more effective than fixed-dose (300 mg) allopurinol in lowering serum uric acid concentration, it had not been shown to be clinically more efficacious or cost effective compared with allopurinol when taken to control uric acid levels (up to 900 mg). However, the committee recommended febuxostat for people who are intolerant of allopurinol.".
- Febuxostat atcPrefix "M04".
- Febuxostat atcSuffix "AA03".
- Febuxostat casNumber "144060-53-7".
- Febuxostat fdaUniiCode "101V0R1N2E".
- Febuxostat iupacName "1,3-thiazole-5-carboxylic acid".
- Febuxostat iupacName "2-(3-cyano-4-isobutoxyphenyl)-4-methyl-".
- Febuxostat pubchem "134018".
- Febuxostat thumbnail Febuxostat.svg?width=300.
- Febuxostat wikiPageID "11289610".
- Febuxostat wikiPageRevisionID "601367628".
- Febuxostat atcPrefix "M04".
- Febuxostat atcSuffix "AA03".
- Febuxostat bioavailability "~49% absorbed".
- Febuxostat c "16".
- Febuxostat casNumber "144060".
- Febuxostat chembl "1164729".
- Febuxostat chemspiderid "118173".
- Febuxostat eliminationHalfLife "-28800.0".
- Febuxostat excretion "urine ; feces".
- Febuxostat h "16".
- Febuxostat hasPhotoCollection Febuxostat.
- Febuxostat inchi "1".
- Febuxostat inchikey "BQSJTQLCZDPROO-UHFFFAOYAV".
- Febuxostat iupacName "13".
- Febuxostat iupacName "2".
- Febuxostat kegg "D01206".
- Febuxostat legalUs "Rx-only".
- Febuxostat licenceEu "Adenuric".
- Febuxostat licenceUs "Febuxostat".
- Febuxostat medlineplus "a609020".
- Febuxostat metabolism "via CYP1A2, 2C8, 2C9, UGT1A1, 1A3, 1A9, 2B7".
- Febuxostat molecularWeight "316.374".
- Febuxostat n "2".
- Febuxostat o "3".
- Febuxostat pregnancyCategory "C".
- Febuxostat proteinBound "~99% to albumin".
- Febuxostat pubchem "134018".
- Febuxostat routesOfAdministration "oral".
- Febuxostat s "1".
- Febuxostat smiles "N#Cc1ccccc2ncC".
- Febuxostat stdinchi "1".
- Febuxostat stdinchikey "BQSJTQLCZDPROO-UHFFFAOYSA-N".
- Febuxostat tradename "Uloric".
- Febuxostat unii "101".
- Febuxostat verifiedfields "changed".
- Febuxostat verifiedrevid "459437484".
- Febuxostat subject Category:Antigout_agents.
- Febuxostat subject Category:Carboxylic_acids.
- Febuxostat subject Category:Nitriles.
- Febuxostat subject Category:Phenol_ethers.
- Febuxostat subject Category:Thiazoles.
- Febuxostat subject Category:Xanthine_oxidase_inhibitors.
- Febuxostat type Abstraction100002137.
- Febuxostat type Acid114607521.
- Febuxostat type CarboxylicAcid114739360.
- Febuxostat type CarboxylicAcids.
- Febuxostat type Chemical114806838.
- Febuxostat type Compound114818238.
- Febuxostat type Element114840755.
- Febuxostat type Material114580897.
- Febuxostat type Matter100020827.
- Febuxostat type Nitrile114827346.
- Febuxostat type Nitriles.
- Febuxostat type OrganicCompound114727670.
- Febuxostat type Part113809207.
- Febuxostat type PhenolEthers.
- Febuxostat type PhysicalEntity100001930.
- Febuxostat type Quintessence114847103.
- Febuxostat type Relation100031921.
- Febuxostat type Substance100019613.
- Febuxostat type Drug.
- Febuxostat type DrugProduct.
- Febuxostat type FunctionalSubstance.
- Febuxostat comment "Febuxostat (INN; trade names: Adenuric in Europe and New Zealand, Febutaz in India and Takeda's Uloric in the US) is a urate lowering drug, an inhibitor of xanthine oxidase that is indicated for use in the treatment of hyperuricemia and chronic gout.Febuxostat received marketing approval by the European Medicines Agency on April 21, 2008 and was approved by the U.S.".
- Febuxostat label "Febuksostat".
- Febuxostat label "Febuxostat".
- Febuxostat label "Febuxostat".
- Febuxostat label "Febuxostat".
- Febuxostat label "Febuxostat".
- Febuxostat label "Febuxostat".
- Febuxostat label "フェブキソスタット".
- Febuxostat sameAs Febuxostat.
- Febuxostat sameAs Febuxostat.
- Febuxostat sameAs Febuxostat.
- Febuxostat sameAs Febuxostat.
- Febuxostat sameAs フェブキソスタット.
- Febuxostat sameAs Febuksostat.
- Febuxostat sameAs m.02r6gv5.
- Febuxostat sameAs Q417296.
- Febuxostat sameAs Q417296.
- Febuxostat sameAs Febuxostat.
- Febuxostat wasDerivedFrom Febuxostat?oldid=601367628.
- Febuxostat depiction Febuxostat.svg.
- Febuxostat isPrimaryTopicOf Febuxostat.